Clinical Trial Update: Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pacritinib with decitabine or cytarabine in older patients with acute myeloid leukemia was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Dacogen (decitabine)
• Pacritinib (pacritinib)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: TERMINATED | Results posted: 2018-06-15